ABERRANT EXPRESSION OF FCΓ RIIIA CONTRIBUTES TO DEVELOPMENT OF ATHEROSCLEROSIS

被引：0
|
作者：
Huang Ye [1 ]
Yin Huijun [1 ]
Wang Jingshang [1 ]
Liu Qian [1 ]
Cao Yali [1 ]
Liu Sijin [2 ]
Chen Keji [1 ]
机构：
[1] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China
[2] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China
来源：
HEART | 2011年 / 97卷
关键词：
D O I：
10.1136/heartjnl-2011-300867.176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Correlation of FcγRIIIa polymorphisms and responses to rituximab in Thai population
    Somboonyosdech, Chayapol
    Wittayalertpanya, Supeecha
    Bunworasate, Udomsak
    Limpanasithikul, Wacharee
    ASIAN BIOMEDICINE, 2012, 6 (06) : 883 - 889
  • [32] Apoptosis of mouse mast cells is reciprocally regulated by the IgG receptors Fc?RIIB and Fc?RIIIA
    Fang, Y.
    Larsson, L.
    Bruhns, P.
    Xiang, Z.
    ALLERGY, 2012, 67 (10) : 1233 - 1240
  • [33] Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE:: a unifying hypothesis
    Magnusson, V
    Johanneson, B
    Lima, G
    Odeberg, J
    Alarcón-Segivuam, D
    Alarcón-Riquelme, ME
    GENES AND IMMUNITY, 2004, 5 (02) : 130 - 137
  • [34] Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE: a unifying hypothesis
    V Magnusson
    B Johanneson
    G Lima
    J Odeberg
    D Alarcón-Segovia
    M E Alarcón-Riquelme
    Genes & Immunity, 2004, 5 : 130 - 137
  • [35] Changes in FcγRIIIA signalling induced by nonenzymatic glucosilation of IgG
    Hirt, M
    Cheta, D
    Popescu, I
    Sulica, A
    Manciulea, M
    DIABETOLOGIA, 1998, 41 : A102 - A102
  • [36] TRANSGENIC EXPRESSION OF HUMAN FC-GAMMA-RIIIA MODULATES MOUSE IGG3 SERUM CONCENTRATION
    GREENSPAN, N
    NOWACEK, D
    GLASS, D
    WIRTHMUELLER, U
    LI, M
    RAVETCH, J
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A66 - A66
  • [37] Polymorphisms in FcγRIIIA (CD 16) receptor expression are associated with clinical response to rituximab in Waldenstrom's macroglobulinemia
    Treon, SP
    Hansen, M
    Branagan, AR
    Verselis, S
    Emmanouilides, C
    Kimby, E
    Frankel, SR
    Touroutoglou, N
    Turnbull, B
    Anderson, KC
    Maloney, DG
    Fox, EA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) : 474 - 481
  • [38] FCγRIIa and FCγRIIIa single nucleotide polymorphisms (SNPs) and cetuximab benefit in the EXCITE trial
    Sclafani, F.
    Gollins, S.
    Cunningham, D.
    Wilson, S. Hulkki
    Kouvelakis, K.
    Lopes, A.
    West, N.
    Quirke, P.
    Begum, R.
    Valeri, N.
    Beare, S.
    Hughes, L.
    De Castro, D. Gonzalez
    Chau, I.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Heterogeneous expression of the 158V and 158F alleles in FcγRIIIA heterozygous donors.
    Dechant, M
    Poellot, T
    Kunzendorf, U
    Valerius, T
    BLOOD, 2004, 104 (11) : 382A - 383A
  • [40] FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt
    Eyada, Tayseer K.
    Farawela, Hala M.
    Khorshied, Mervat M.
    Shaheen, Iman A.
    Selim, Neama M.
    Khalifa, Iman A. S.
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (01) : 64 - 68
12345